Table of Contents Table of Contents
Previous Page  86 / 88 Next Page
Information
Show Menu
Previous Page 86 / 88 Next Page
Page Background

84

NCCN Guidelines for Patients

®

:

Breast Cancer – Locally Advanced (STAGE III)

Version 1.2017

Index

Index

2nd opinion

72

biopsy

17, 19–21, 37, 39–40, 42, 45, 62

blood tests

23, 25, 54, 62

breast-conserving therapy

38, 58, 63, 72

breast reconstruction

40–42, 72

cancer stage

12–13, 37, 45–46

chemotherapy

13–15, 27–34, 44, 46, 52, 54, 63

clinical trial

14–15, 68

endocrine therapy

13–15, 27, 42, 44, 52–56, 58, 60,

63

fertility

24–25

HER2

17, 22–23, 25, 27–32, 34, 44, 52, 58, 62–63

hereditary breast cancers

17

hormone receptor

17, 22–23, 25, 27, 52, 54, 56, 62

hormone therapy

see endocrine therapy

imaging tests

18–20, 25, 34, 58–59, 62, 72

immunohistochemistry

22–23

lumpectomy

13–14, 36, 38–42, 46–47, 60

lymph node

8–9, 12–15, 18–21, 36–37, 39–42, 44,

46–47, 58, 63–64

mammogram

17–19, 40, 58–60

mastectomy

13–14, 36–42, 46–47, 58, 63, 72

medical history

17–18, 25, 58–59, 62

NCCN Member Institutions

83

NCCN Panel Members

82

nipple replacement

42

pathology report

21–72

physical exam

17–18, 21, 34, 45, 58–60, 62

radiation therapy

13–15, 34, 38, 41–42, 44–50, 52,

56, 59, 63–64

sentinel lymph node biopsy

21

supportive care

34